archive-org.com » ORG » I » ISLET.ORG

Total: 491

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • The Streetlight Effect Is There Light at the End of the Tunnel?
    University of Florida Gainesville FL Corresponding author Mark A Atkinson atkinson ufl edu Abstract In the nearly 100 years since the discovery of therapeutic insulin significant research efforts have been directed at finding the underlying cause of type 1 diabetes T1D and developing a cure for the disease While progress has clearly been made toward each of these goals neither vision has been fulfilled With increasing pressure from both public and private funders of diabetes research growing impatience of those with T1D at the lack of practical discoveries increased competition for research funds uncertainties on the reproducibility of published scientific data and questions regarding the value of animal models the current research environment has become extraordinarily difficult to traverse from the perspective of investigators As a result there is an increasing pressure toward performance of what might be considered safe research where the aim is to affirm existing dogmas rather than to pioneer efforts involving unconventional thought Psychologists refer to this practice as observational bias while cartoonists label the process the streetlight effect In this Perspective we consider notions in T1D research that should be subject to bold question and provide additional concepts many somewhat orphan to research efforts whose

    Original URL path: http://islet.org/forum/messages/56002.htm (2016-04-29)
    Open archived version from archive


  • Professor Elliott steps down from executive position
    steps down from executive position Co founder Emeritus Professor Bob Elliott will step down from the position of Executive Director Clinical Research and Innovation with effect from 27 February 2015 He will continue as a board director of LCT and chairman of 50 joint venture company Diatranz Otsuka Limited http www lctglobal com Follow Ups Re Professor Elliott steps down from executive position elliott 17 22 32 2015 03 31

    Original URL path: http://islet.org/forum/messages/55997.htm (2016-04-29)
    Open archived version from archive

  • Re: Professor Elliott steps down from executive position
    What has been accomplished is 1 establishing the safety of xenotransplantation 2 convincing evidence that unawre hypoglycemia can be cutailed by such transplanation with modets reduction in insulin dose and HbA1c Two quite large teams OPF and DOL are working on product improvement aimed at produicing insulin independence and funding is no longer a major concern It is no longer a one man show with tenuous funding Follow Ups Re

    Original URL path: http://islet.org/forum/messages/56003.htm (2016-04-29)
    Open archived version from archive

  • Re: Professor Elliott steps down from executive position
    05 In Reply to Re Professor Elliott steps down from executive position posted by elliott Thanks a lot We understand it is not easy to get the cure and what you have contributed has beyond most others have done Follow

    Original URL path: http://islet.org/forum/messages/56007.htm (2016-04-29)
    Open archived version from archive

  • Re: Professor Elliott steps down from executive position
    by Ellen Professor Elliott is a true hero in the world of diabetes research The good news is that Bob Elliott s knowledge experience focus and integrity will still be part of LCT and Diatranz Otsuka as they drive to develop a cure for diabetes that can benefit millions of sufferers without the risks of toxic systemic immunosuppression We cannot thank you enough Bob Al Follow Ups Re Professor Elliott

    Original URL path: http://islet.org/forum/messages/55998.htm (2016-04-29)
    Open archived version from archive

  • Re: Professor Elliott steps down from executive position
    DIABECELL Under the new strategy DOL will partner with Otsuka Pharmaceutical Factory Inc OPF its other 50 shareholder to support the development and launch of DIABECELL in United States of America DOL and OPF will focus on developing a DIABECELL product that will meet FDA regulatory requirements Approval by the FDA will facilitate approval for the product across the rest of the world This will reduce the funding requirements for

    Original URL path: http://islet.org/forum/messages/55999.htm (2016-04-29)
    Open archived version from archive

  • Re: Professor Elliott steps down from executive position
    by Rene on 08 51 11 2015 03 21 In Reply to Re Professor Elliott steps down from executive position posted by Frank Cz Very strange if they do not start first in Europe as European market approval is both faster cheaper and easier less restrictive And with European approval the FDA approval is subsequently faster cheaper and easier to obtain Follow Ups Post a Followup Name E Mail Optional

    Original URL path: http://islet.org/forum/messages/56001.htm (2016-04-29)
    Open archived version from archive

  • 19.5 years (son)
    Also as an empty nester daughter is age 20 and in college Trevor is out of school and working I would be happy to come to work in whatever manner for any of the Scientists Companies that I have seen making the valiant effort and still plugging away Any careers for A Waiting TIF er Warm or 4 season s climate is a must Far North Michigan will gladly be

    Original URL path: http://islet.org/forum/messages/55992.htm (2016-04-29)
    Open archived version from archive



  •